BlackRock Science and Technology Trust II (BSTZ) is a strategically managed closed-end fund by BlackRock, focusing on high-growth investments within the science and technology sectors. With a keen emphasis on innovative companies that are at the forefront of technological advancements and scientific research, BSTZ aims to capitalize on the substantial growth potential in these dynamic fields. Backed by BlackRock's extensive market expertise, the trust seeks to provide attractive total returns through a combination of capital appreciation and income generation. This fund is particularly appealing to institutional investors looking to diversify their portfolios and gain exposure to long-term trends in technological innovation and healthcare developments.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.90 |
| Price-to-Sales (TTM) | 4.86 |
| EV/Revenue | 4.862 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $68.74M |
| Float | 0 |
| % Insiders | 0.01% |
| % Institutions | 31.00% |
Volatility is currently expanding